“When Heptares formed, we chose to focus on GPCRs because we knew that targeting these receptors leads to drugs,” says Matt Barnes, president and head of R&D at Nxera Pharma. GPCRs are ...

Beacon Discovery was launched in 2016; however, its founding team of five scientists guided the drug discovery arm of GPCR-focused Arena Pharmaceuticals for more than 15 years. When Arena pivoted ...